Skip to main content

Table 7 Comparative pharmacophoric 3D features for AQ (lead) and top 16 predicted active congeners

From: In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors

Compound ID

Pharmacophoric 3D features predicted by our models

Quinoline

N1

4-amino

4-anilino benzene

R7

R′3

R′4

R′5

AQ (Lead)

H; AR

HBA

HBD

AR

H

PI; H

HBA; HBD

-

659

H; AR

HBA

HBD

AR

H; HBA

PI

HBA;HBD

PI

649

H; AR

HBA

HBD

AR

H; HBA

PI

HBD

PI

289

H; AR

HBA

HBD

AR

H

PI

HBD

PI

299

H; AR

HBA

HBD

AR

H

PI

HBA;HBD

PI

1029

H; AR

HBA

HBD

AR

H

PI

HBA;HBD

PI

1009

H; AR

HBA

HBD

AR

H

PI

HBD

PI

1019

H; AR

HBA

HBD

AR

H

PI

HBA;HBD

PI

403

H; AR

HBA

HBD

AR

H; HBA

PI

HBD

PI

454

H; AR

HBA

HBD

AR

H; HBA

PI; H; H

HBA;HBD

PI; H; H

413

H; AR

HBA

HBD

AR

H; HBA

PI

HBA;HBD

PI

464

H; AR

HBA

HBD

AR

H; HBA

PI; H; H

HBA;HBD

PI; H; H

444

H; AR

HBA

HBD

AR

H; HBA

PI; H; H

HBD

PI; H; H

340

H; AR

HBA

HBD

AR

H

AR; H; H

HBA;HBD

AR; H; H

597

H; AR

HBA

HBD

AR

H; HBA

PI; H; H

HBA; H; AR

PI; H; H

577

H; AR

HBA

HBD

AR

H; HBA

PI; H; H

HBA;HBD

PI; H; H

43

H; AR

HBA

HBD

AR

H

PI

HBD

PI

  1. H hydrophobicity, AR aromaticity, HBD hydrogen bond donor, HBA hydrogen bond acceptor, PI positive ionization